Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/112091
Title: | Parenteral Ready-to-Use Fixed-Dose Combinations Including NSAIDs with Paracetamol or Metamizole for Multimodal Analgesia-Approved Products and Challenges | Authors: | Silva, Fernando Costa, Gustavo Veiga, Francisco Cardoso, Catarina Paiva-Santos, Ana Cláudia |
Keywords: | fixed-dose combination; NSAID; non-opioid analgesic; ready-to-use; parenteral; multimodal analgesia; pain | Issue Date: | 31-Jul-2023 | Publisher: | MDPI | Project: | Fundação para a Ciência e a Tecnologia I.P. (FCT) and Laboratórios Basi from the Drugs R&D Doctoral Program grant number PD/BDE/150684/2020 | Serial title, monograph or event: | Pharmaceuticals | Volume: | 16 | Issue: | 8 | Abstract: | The combination of non-steroidal anti-inflammatory drugs (NSAIDs) with non-opioid analgesics is common in clinical practice for the treatment of acute painful conditions like post-operative and post-traumatic pain. Despite the satisfactory results achieved by oral analgesics, parenteral analgesia remains a key tool in the treatment of painful conditions when the enteral routes of administration are inconvenient. Parenteral ready-to-use fixed-dose combinations of non-opioid analgesics combinations, including NSAIDs and paracetamol or metamizole, could play a central role in the treatment of painful conditions by combining the advantages of multimodal and parenteral analgesia in a single formulation. Surprisingly, only in 2020, a parenteral ready-to-use fixed-dose combination of ibuprofen/paracetamol was launched to the market. This review aims to investigate the current availability of combinations of NSAIDs with paracetamol or metamizole in both European and American markets, and how the combination of such drugs could play a central role in a multimodal analgesia strategy. Also, we explored how the parenteral formulations of NSAIDs, paracetamol, and metamizole could serve as starting elements for the development of new parenteral ready-to-use fixed-dose combinations. We concluded that, despite the well-recognized utility of combining NSAIDs with paracetamol or metamizole, several randomized clinical trial studies demonstrate no clear advantages concerning their efficacy and safety. Future clinical trials specifically designed to assess the efficacy and safety of pre-formulated fixed-dose combinations are required to generate solid evidence about their clinical advantages. | URI: | https://hdl.handle.net/10316/112091 | ISSN: | 1424-8247 | DOI: | 10.3390/ph16081084 | Rights: | openAccess |
Appears in Collections: | I&D CIBB - Artigos em Revistas Internacionais I&D ICBR - Artigos em Revistas Internacionais FFUC- Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Parenteral-ReadytoUse-FixedDose-Combinations-Including-NSAIDs-with-Paracetamol-or-Metamizole-for-Multimodal-AnalgesiaApproved-Products-and-ChallengesPharmaceuticals.pdf | 486.33 kB | Adobe PDF | View/Open |
Page view(s)
53
checked on Aug 28, 2024
Download(s)
39
checked on Aug 28, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License